CASI Pharmaceuticals (CASIF) Other Non Operating Income (2022 - 2025)

CASI Pharmaceuticals (CASIF) has 4 years of Other Non Operating Income data on file, last reported at -$15000.0 in Q4 2025.

• Quarterly Other Non Operating Income fell 188.24% year-over-year to -$15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$418000.0 (down 322.34% YoY) and the FY2025 annual result came in at $20000.0, down 89.36% from the prior year.
• Other Non Operating Income grew to -$15000.0 in Q4 2025, from -$433000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.3 million in Q1 2023 to a low of -$2.7 million in Q4 2023.
• A 4-year average of -$69187.5 and a median of $11500.0 in 2022 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 4200.0% in 2023, down 17025.0% in 2023.
• Tracing CASIF's Other Non Operating Income over 4 years: stood at -$16000.0 in 2022, then sank by 17025.0% to -$2.7 million in 2023, then surged by 100.62% to $17000.0 in 2024, then sank by 188.24% to -$15000.0 in 2025.
• The last three Other Non Operating Income figures came in at -$15000.0 (Q4 2025), -$433000.0 (Q3 2025), and $12000.0 (Q2 2025), per Business Quant data.